Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

Effects of SGLT2 inhibitor on tumor‐releasing chemokines/cytokines in Hep3B and Huh7 cells

Bibliografski detalji
Glavni autori:	Dan Nakano, Takumi Kawaguchi, Tsubasa Tsutsumi, Masako Hayakawa, Sachiyo Yoshio, Hironori Koga, Takuji Torimura
Format:	Članak
Jezik:	English
Izdano:	Wiley 2022-04-01
Serija:	JGH Open
Teme:	chemokine cytokine hepatoma sodium‐glucose cotransporter 2 tumor microenvironment
Online pristup:	https://doi.org/10.1002/jgh3.12730

Slični predmeti

Gene cloning and expression analysis of Gro/KC by primary hepatocytes
od: GH. Hassanshahi, i dr.
Izdano: (2007-01-01)

Drug Transporter Expression and Activity in Human Hepatoma HuH-7 Cells
od: Elodie Jouan, i dr.
Izdano: (2016-12-01)

Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
od: Toru Nakamura, i dr.
Izdano: (2024-10-01)

Chemokines, chemokine receptors and disease : current topics in membranes /
od: Schwiebert, Lisa M.
Izdano: (2005)

A rapid increase in lysophospholipids after geranylgeranoic acid treatment in human hepatoma-derived HuH-7 cells revealed by metabolomics analysis
od: Yoshihiro Shidoji, i dr.
Izdano: (2021-12-01)

Suppression Effect of Eurycomanone on the Growth of Human Hepatoma Cells (Hepg2) by Inducing P53-Mediated Apoptotic Pathway
od: Zakaria, Yusmazura
Izdano: (2009)

Düzeltme: Gossypinin insan hepatom (Hep-3B) hücreleri üzerindeki antiproliferatif etkisi
od: İrfan Çınar
Izdano: (2021-03-01)

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
od: Valeria Mollica Poeta, i dr.
Izdano: (2019-03-01)

Chemokines and chemokine receptors expression in the lesions of patients with American cutaneous leishmaniasis
od: Nilka Luisa Diaz, i dr.
Izdano: (2013-06-01)

The role of chemokines and chemokine receptors in eosinophil activation during inflammatory allergic reactions
od: Oliveira S.H.P., i dr.
Izdano: (2003-01-01)

Role of Chemokines and Chemokine Receptors in Rheumatoid Arthritis
od: Elemam NM, i dr.
Izdano: (2020-03-01)

Seric chemokines and chemokine receptors in eosinophils during acute human schistosomiasis mansoni
od: Denise Silveira-Lemos, i dr.
Izdano: (2010-07-01)

Chemokines and chemokine receptors in Behçet’s disease
od: Zhan Li, i dr.
Izdano: (2023-01-01)

Targeting Chemokines and Chemokine GPCRs to Enhance Strong Opioid Efficacy in Neuropathic Pain
od: Martina Vincenzi, i dr.
Izdano: (2022-03-01)

Chemokines and chemokine receptors as promising targets in rheumatoid arthritis
od: Masanori A. Murayama, i dr.
Izdano: (2023-02-01)

The Value of Chemokine and Chemokine Receptors in Diagnosis, Prognosis, and Immunotherapy of Hepatocellular Carcinoma
od: Wu Z, i dr.
Izdano: (2024-05-01)

Chemokines and chemokine receptors: A new strategy for breast cancer therapy
od: Hui Liu, i dr.
Izdano: (2020-06-01)

EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS
od: A. S. Beltiukova, i dr.
Izdano: (2014-07-01)

Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway
od: Wenyue Zhang, i dr.
Izdano: (2020-07-01)

SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study
od: Yanchen Lv, i dr.
Izdano: (2024-05-01)

The impacts of SGLT2 inhibitors on the mortality of patients with tuberculosis
od: Chung-Shu Lee, i dr.
Izdano: (2025-05-01)

Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
od: Nicolas Jacquelot, i dr.
Izdano: (2018-10-01)

Chemokine biology : basic research and clinical application /
od: Moser, Bernhard, 1956-, i dr.
Izdano: (2006)

Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System
od: Amanda E. I. Proudfoot, i dr.
Izdano: (2017-08-01)

Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
od: Dhaiban S, i dr.
Izdano: (2020-09-01)

SGLT2 Inhibitors as Potential Anticancer Agents
od: Debasish Basak, i dr.
Izdano: (2023-06-01)

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
od: Takumi Kawaguchi, i dr.
Izdano: (2022-04-01)

Chemokines in tumor proximal fluids
od: Jaromír Kotyza
Izdano: (2017-03-01)

CC chemokines and receptors in osteoarthritis: new insights and potential targets
od: Yuchen Zhang, i dr.
Izdano: (2023-07-01)

Metástasis raquídea de hepatocarcinoma
od: Pedro Benedek, i dr.
Izdano: (1979-03-01)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
od: M.Saadat, i dr.
Izdano: (1998-12-01)

Anticarcinogenic Efficacy of Fucoxanthin on HepG2 Cell Lines
od: P Sangavi, i dr.
Izdano: (2022-02-01)

Cytokines, Chemokines, and Chemokine Receptors Quantitative Expressions in Patients with Ovarian Cancer
od: Somayeh Rezaeifard, i dr.
Izdano: (2015-05-01)

Chemokine Biology [electronic resource]: Basic Research and Clinical Application/
od: Neote, Kuldeep, i dr.
Izdano: (2007)

Chemokine Biology [electronic resource]: Basic Research and Clinical Application/
od: Neote, Kuldeep, i dr.
Izdano: (2007)

Chemokines in Innate and Adaptive Granuloma Formation
od: Stephen Wesley Chensue
Izdano: (2013-02-01)

Advances in chemokines of teleost fish species
od: Hongsen Xu, i dr.
Izdano: (2024-03-01)

Perspective: Insights on the Nomenclature of Cytokines and Chemokines
od: Albert Zlotnik
Izdano: (2020-05-01)

GENE POLYMORPHISM ANALYSIS OF CHEMOKINES, CHEMOKINE RECEPTORS, ACUTE PHASE PROTEINS, AND CD14 IN FEMALE OBESITY DEVELOPMENT
od: O. V. Kochetova, i dr.
Izdano: (2018-11-01)

Inflammatory Chemokines in Atherosclerosis
od: Selin Gencer, i dr.
Izdano: (2021-01-01)